As America turns 250, one museum makes history possible to touch
Federal law requires most museums and other buildings to be accessible to people with disabilities. But access to what's actually inside is often still limited.
Read full article →Latest Healthcare Policy news from across the web.
Federal law requires most museums and other buildings to be accessible to people with disabilities. But access to what's actually inside is often still limited.
Read full article →RFK Jr. presents funding intended to address mental illness and addiction, particularly among homeless people.
Read full article →The speed of DOJ's proposed antitrust settlement with OhioHealth should put other hospitals on notice, experts say.
Read full article →The FTC and four state attorneys general have sued the main professional organization for gender-affirming care clinicians.
Read full article →A new study found that two diversity-oriented programs supported by the NIH doubled the odds that an undergraduate would earn a Ph.D.
Read full article →Luigi Mangione plans to assert a psychiatric defense at his state murder trial, claiming he was suffering from extreme emotional disturbance when he gunned down UnitedHealthcare CEO Brian Thompson.
Read full article →More than 60 organizations are urging the FDA to withdraw approval for what they called the “unsafe” use of antibiotics for preventing disease in food-producing livestock.
Read full article →UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news
Read full article →A cyber extortion group claimed to have stolen more than a terabyte of data from Novo Nordisk and said it is exploring selling some of the data
Read full article →In this edition of AI Prognosis, Brittany Trang takes a close look at ambient scribe developer Abridge's claim about being patient-centered.
Read full article →Infant mortality rate dips, OTC naloxone options rise, and other health news from Morning Rounds
Read full article →The FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.
Read full article →